<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876406</url>
  </required_header>
  <id_info>
    <org_study_id>C.P. - C.I. 16/359-E</org_study_id>
    <nct_id>NCT02876406</nct_id>
  </id_info>
  <brief_title>ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery</brief_title>
  <official_title>Using the ΔvapCO2 / Cav02 Ratio as a Prognostic Marker and Predictor of Complications After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital San Carlos, Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital San Carlos, Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the usefulness of the ΔvapCO2 / Cav02 ratio to predict complications
      after elective cardiac surgery, comparing it with others markers such as lactate,
      arteriovenous CO2 difference (ΔvapCO2) and would try to developed a new predictive score for
      postoperative complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiac surgery is widely used to solve valvular or coronary problems and often requires the
      use of cardiopulmonary bypass or extracorporeal circulation (EC).

      The EC itself produces a series of changes in the macro- and microcirculation hemodynamic and
      physiological consequences in the hours following surgery that can be difficult to analyze.

      During postoperatively management, different monitoring methods are used to optimize
      different hemodynamic and analytical variables.

      Sometimes, monitored variables are corrected but the patient still develops complications
      such as kidney failure, prolonged mechanical ventilation or even death. In fact, it is not
      well known either if it is sufficient to correct the variables called &quot;macrodynamics &quot; such
      as mean arterial pressure (MAP) , stroke volume (SV), pulmonary artery occlusion pressure
      (PCWP) and cardiac index (CI) or if it is necessary to correct other &quot;micro-dynamics&quot;
      variables like lactate, to achieve a certain central venous oxygen saturation (ScvO2) or
      arteriovenous CO2 difference(ΔvapCO2).

      In tissue hypoxia, damping of excess protons by bicarbonate increase CO2 production;
      therefore the relationship between CO2 production and oxygen consumption (VCO2/VO2 ratio or
      respiratory quotient) increases. This ratio can be simplified relating ΔvapCO2 and O2 content
      arteriovenous difference (ΔvapCO2 / Cav02 ratio). In shock, anaerobic metabolism is one of
      the primary energy source. In this situation, ΔvapCO2 / Cav02 is &gt; 1.

      The evolution of the ΔvapCO2 / Cav02 ratio and its association with prognosis have nnot been
      studied yet after cardiac surgery.

      The study`s objectives are:

        -  to describe ΔvapCO2 / Cav02 ratios kinetics compared to lactate and other biochemical
           markers (troponin I, BE) in the first 12 hours after cardiac surgery.

        -  define if ΔvapCO2 / Cav02 ratio&gt; 1 after 6 hours of adequate postsurgical resuscitation
           correlates with worse prognosis in patients after cardiac surgery.

        -  develop a new prognostic score for postoperative complication that includes ΔvapCO2 /
           Cav02 ratio.

      Blood gases and drawn from a central venous and arterial lines. pCO2, O2 content, lactate are
      analyzed at 0, 2, 6 and 12 hs. Macrodynamic variables are also collected, as well as, the
      need of extracorporeal support techniques.

      Patients would be followed for the next 28 days after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>28 Days</target_duration>
  <primary_outcome>
    <measure>all cause mortality</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>all cause intra-ICU mortality</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilator days</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
    <description>Time that is required to extubate the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU stay length</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital stay length</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute kidney failure</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
    <description>According RIFLE classification</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vasoactive requirements after 12 hs</measure>
    <time_frame>First 12 hs postoperative</time_frame>
    <description>Noradrenaline or dobutamine requirement after 12 hs (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume infused over 12 hs (ml)</measure>
    <time_frame>First 12 hs postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraaortic counterpulsation balloon</measure>
    <time_frame>First 12 hs postoperative</time_frame>
    <description>Need of Intraaortic baloon counterpulsation (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular mechanical assistance</measure>
    <time_frame>First 12 hs postoperative</time_frame>
    <description>Need of ventricular mechanical assistance (yes/no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal replacement therapies</measure>
    <time_frame>within the first 28 days after surgery</time_frame>
    <description>Need of renal replacement therapies (yes/no)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Disorder of Blood Gas</condition>
  <condition>Postoperative Complications</condition>
  <condition>Shock</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing elective cardiac surgery in an university hospital that would be
        followed during the postoperative time in the Cardiovascular Intensive Care Unit.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or more

          -  given informed consent

          -  elective cardiac surgery

          -  tip of a central venous catheter correctly positioned (superior vena cava or right
             atria)

          -  arterial catheter correctly positioned

        Exclusion criteria:

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tomás F Fariña González, MD</last_name>
    <phone>+ 34 91 3303223</phone>
    <email>tomas_scout@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fernando Martinez Sagasti, PhD</last_name>
    <email>fmsagasti@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomás F Fariña González, MD</last_name>
      <email>tomas_scout@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Tomás F Fariña González, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Du W, Long Y, Wang XT, Liu DW. The Use of the Ratio between the Veno-arterial Carbon Dioxide Difference and the Arterial-venous Oxygen Difference to Guide Resuscitation in Cardiac Surgery Patients with Hyperlactatemia and Normal Central Venous Oxygen Saturation. Chin Med J (Engl). 2015 May 20;128(10):1306-13. doi: 10.4103/0366-6999.156770.</citation>
    <PMID>25963349</PMID>
  </reference>
  <reference>
    <citation>Hu BY, Laine GA, Wang S, Solis RT. Combined central venous oxygen saturation and lactate as markers of occult hypoperfusion and outcome following cardiac surgery. J Cardiothorac Vasc Anesth. 2012 Feb;26(1):52-7. doi: 10.1053/j.jvca.2011.07.021. Epub 2011 Sep 15.</citation>
    <PMID>21924630</PMID>
  </reference>
  <reference>
    <citation>Habicher M, von Heymann C, Spies CD, Wernecke KD, Sander M. Central Venous-Arterial pCO2 Difference Identifies Microcirculatory Hypoperfusion in Cardiac Surgical Patients With Normal Central Venous Oxygen Saturation: A Retrospective Analysis. J Cardiothorac Vasc Anesth. 2015;29(3):646-55. doi: 10.1053/j.jvca.2014.09.006. Epub 2015 Jan 6.</citation>
    <PMID>25575410</PMID>
  </reference>
  <reference>
    <citation>Robin E, Futier E, Pires O, Fleyfel M, Tavernier B, Lebuffe G, Vallet B. Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients. Crit Care. 2015 May 13;19:227. doi: 10.1186/s13054-015-0917-6.</citation>
    <PMID>25967737</PMID>
  </reference>
  <reference>
    <citation>Mekontso-Dessap A, Castelain V, Anguel N, Bahloul M, Schauvliege F, Richard C, Teboul JL. Combination of venoarterial PCO2 difference with arteriovenous O2 content difference to detect anaerobic metabolism in patients. Intensive Care Med. 2002 Mar;28(3):272-7. Epub 2002 Feb 8.</citation>
    <PMID>11904655</PMID>
  </reference>
  <reference>
    <citation>Ospina-Tascón GA, Umaña M, Bermúdez W, Bautista-Rincón DF, Hernandez G, Bruhn A, Granados M, Salazar B, Arango-Dávila C, De Backer D. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O 2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015 May;41(5):796-805. doi: 10.1007/s00134-015-3720-6. Epub 2015 Mar 20.</citation>
    <PMID>25792204</PMID>
  </reference>
  <reference>
    <citation>Balzer F, Sander M, Simon M, Spies C, Habicher M, Treskatsch S, Mezger V, Schirmer U, Heringlake M, Wernecke KD, Grubitzsch H, von Heymann C. High central venous saturation after cardiac surgery is associated with increased organ failure and long-term mortality: an observational cross-sectional study. Crit Care. 2015 Apr 16;19:168. doi: 10.1186/s13054-015-0889-6.</citation>
    <PMID>25888321</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital San Carlos, Madrid</investigator_affiliation>
    <investigator_full_name>Tomás Francisco Fariña González</investigator_full_name>
    <investigator_title>Resident Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

